Catherine Connolly has joined Cambridge Antibody Technology as vice president of human resources, and Kathy Lambert has joined the company as vice president of quality, a position in which she will be responsible for ensuring compliance with good manufacturing practice, good clinical practice, and good laboratory practice, the company said this week.
Connolly comes to CAT, of Cambridge, UK, from Simpay, a mobile phone payments company where she was interim human resources advisor. Before joining Simpay, Connolly held human resources positions at Mediaedge, KPMG, and National Westminster Bank. She holds an MA in law from Trinity College Dublin, and a post graduate diploma in HR management from Southbank University.
Lambert joins CAT from Xe-nova Research, where she was director, quality and regulatory affairs. Before that, she was director of UK operations and FDA responsible head at Celltech Biologics, which is now Lonza. Lambert holds a BS in nutrition from the University of London, an MBA from the Open Business School, and a PhD in microbiology from the University of London.
Geoffrey Duyk will leave his post of president, research and development, and chief scientific officer at Exelixis at the end of the year, according to the company. Frank McCormick, who serves on Exelixis’ board of directors, and is director of the University of California, San Francisco Comprehensive Cancer Center, will step up his advisory role on the company’s R&D. Greg Plowman, the company’s senior vice president of research, Michael Morrissey, the company’s senior vice president of discovery research, and Jeffrey Latts, chief medical officer, will remain in their current roles, the company said.